HOME/ABOUT  Prayer  SCOTUS  ProLife  BangList  Aliens  StatesRights  ConventionOfStates  WOT  HomosexualAgenda  GlobalWarming  Corruption  Taxes  Congress  Fraud  MediaBias  GovtAbuse  Tyranny  Obama  ObamaCare  Elections  Layoffs  NaturalBornCitizen  FastandFurious  OPSEC  Benghazi  Libya  IRS  Scandals  TalkRadio  TeaParty  FreeperBookClub  HTMLSandbox  FReeperEd  FReepathon  CopyrightList  Copyright/DMCA Notice  Donate

Dear FRiends, Your loyal support makes Free Republic possible and your continuing participation makes FR the number one grassroots pro-life conservative forum on the planet! If you have not yet made your donation, please click here and do so now. Thank you very much, Jim Robinson

Or by mail to: Free Republic, LLC - PO Box 9771 - Fresno, CA 93794
Free Republic 2nd Quarter Fundraising Target: $88,000 Receipts & Pledges to-date: $31,282
35%  
Woo hoo!! And the first 35% is in!! Thank you all very much!!

Keyword: singulair

Brevity: Headers | « Text »
  • Asthma Drug Label to Include Psychiatric Risk

    07/21/2009 9:08:43 AM PDT · by neverdem · 12 replies · 489+ views
    Family Practice News ^ | 1 July 2009 | LORINDA BULLOCK
    The Food and Drug Administration last month called on manufacturers of leukotriene inhibitors to include safety precautions on their drug's labeling, because of reports of neuropsychiatric events in patients taking these drugs. The FDA said the reported neuropsychiatric events included cases of agitation, aggression, anxiety, dream abnormalities and hallucinations, depression, insomnia, irritability, restlessness, suicidal ideation and behavior, and tremor in patients using montelukast (Singulair), zafirlukast (Accolate), and zileuton (Zyflo, Zyflo CR). Manufacturers of these drugs were asked to submit all available clinical trial data for these products for the safety review that concluded in April. In its review, the FDA...
  • New Jersey Takes The Lead In Confronting Autism

    12/29/2002 7:53:16 PM PST · by Incorrigible · 36 replies · 5,565+ views
    Newark Star Ledger ^ | 12/29/2002 | Carol Ann Campbell
    NEW JERSEY TAKES LEAD IN CONFRONTING AUTISM Researchers are challenging assumptions about the disorder Sunday, December 29, 2002 BY CAROL ANN CAMPBELL Star-Ledger Staff [New Jersey] -- Catherine Wersinger remembered the day she held a cup of juice in front of her son Peter, then 2 1/2 years old and diagnosed with autism. "Say juice, Peter," she called out. "Juice. See, juice! Juice! Just say, 'juh' 'juh!' Can you say, 'juh'?" Her bright-eyed boy stood stone-faced. He could not say one word. Not mama. Not dada. Not juice. Today Peter is among the first autistic children being treated by a...